Wai Shing Chan
This page summarises the Hong Kong Securities and Futures Commission (SFC) public register record for Wai Shing Chan (陳偉成), a licensed Representative with CE reference AGZ885. Currently licensed at 1 firm(s): Invesco Hong Kong Limited. Active regulated activities: Type 1 - Dealing in securities; Type 2 - Dealing in futures contracts; Type 9 - Asset management. This person has 23.2 years of SFC licence history. Total licence records on file: 10.
Information
- LinkedIn:
- Email:
Licence history
| Firm | Role | Regulated activity | From | To |
|---|---|---|---|---|
| Invesco Hong Kong Limited 景順投資管理有限公司(以景順投資管理名義經營業務) |
Rep | Type 2 - Dealing in futures contracts | 2022-03-24 | present |
| Invesco Hong Kong Limited 景順投資管理有限公司(以景順投資管理名義經營業務) |
Rep | Type 1 - Dealing in securities | 2013-01-16 | present |
| Invesco Hong Kong Limited 景順投資管理有限公司(以景順投資管理名義經營業務) |
Rep | Type 9 - Asset management | 2007-06-27 | present |
| Invesco Asset Management Asia Limited 景順投資管理亞洲有限公司 |
Rep | Type 1 - Dealing in securities | 2013-01-16 | 2021-12-31 |
| Lombard Odier (Hong Kong) Limited 瑞士隆奧(香港)有限公司 |
RO | Type 1 - Dealing in securities | 2006-11-13 | 2007-06-22 |
| Lombard Odier (Hong Kong) Limited 瑞士隆奧(香港)有限公司 |
Rep | Type 1 - Dealing in securities | 2005-05-26 | 2006-11-13 |
| Lombard Odier (Hong Kong) Limited 瑞士隆奧(香港)有限公司 |
Rep | Type 9 - Asset management | 2005-04-20 | 2007-06-22 |
| PineBridge Investments Asia Limited 柏瑞投資亞洲有限公司 |
Rep | Type 4 - Advising on securities | Pre-2003 | 2005-03-31 |
| PineBridge Investments Asia Limited 柏瑞投資亞洲有限公司 |
Rep | Type 6 - Advising on corporate finance | Pre-2003 | 2005-03-15 |
| PineBridge Investments Asia Limited 柏瑞投資亞洲有限公司 |
Rep | Type 9 - Asset management | Pre-2003 | 2005-04-20 |
Worked alongside
The 20 closest colleagues, strongest tie first — individuals licensed at the same firm as Wai Shing Chan during overlapping periods. Ranked by how long they overlapped and how similar their regulated activities were, with shared time at a smaller firm weighted more than at a large one. See the detailed formula.